Literature DB >> 30657555

Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.

B Cheng1, F Ding, C-Y Huang, H Xiao, F-Y Fei, J Li.   

Abstract

OBJECTIVE: The aim of this study was to investigate the role of miR-16-5p in hepatocellular carcinoma (HCC), and to explore the possible underlying mechanism. PATIENTS AND METHODS: 100 pairs of cancerous and para-cancerous tissues surgically removed in our hospital were collected. Real Time quantitative-Polymerase Chain Reaction (qRT-PCR) was used to detect the expression level of miR-16-5p in tissues. Bioinformatics and Dual-Luciferase reporter gene assay were used to screen and verify the potential target genes of miR-16-5p, respectively. Human HCC SMMC-7721 cells were used for functional experiments. Cell proliferation was detected by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. Cell invasion and migration were evaluated by transwell and scratch wound-healing assay, respectively. The protein expression levels of epithelial-mesenchymal transition (EMT) associated markers were measured by Western blot (WB) assay.
RESULTS: QRT-PCR showed that miR-16-5p expression in HCC tissues was significantly lower than that of adjacent normal liver tissues. At the cellular level, miR-16-5p was lowly expressed in HCC cells (SMMC-7721). Bioinformatics websites (including Targetscan, PicTar, miRanda) predicted that insulin-like growth factor 1 receptor (IGF1R) was a potential target gene of miR-16-5p. Meanwhile, IGF1R was selected for further investigation due to its metastatic function. The results showed that no significant difference was found in the mRNA expression level of IGF1R in HCC tissues. However, the protein level of IGF1R was significantly up-regulated, which was negatively correlated with miR-16-5p. Combined with Dual-Luciferase reporter gene assay, it was confirmed that miR-16-5p could regulate the expression of IGF1R in a targeted manner. Furthermore, down-regulation of IGF1R significantly reduced the inhibitory effect of miR-16-5p on the proliferation and metastasis of SMMC-7721 cells.
CONCLUSIONS: We showed that miR-16-5p suppressed invasion and migration of HCC cells, mechanically by directly targeting and inhibiting IGF1R protein expression. The newly identified miR-16-5p/IGF1R axis might provide new insights into the pathogenesis of HCC and novel potential therapeutic targets for the treatment of HCC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30657555     DOI: 10.26355/eurrev_201901_16757

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  Downregulation of hsa_circ_0000885 suppressed osteosarcoma metastasis and progression via regulating E2F3 expression and sponging miR-16-5p.

Authors:  Yanfang Li; Zhiqing Wu; Jianlin Shen
Journal:  Regen Ther       Date:  2022-06-22       Impact factor: 3.651

2.  Effect and Mechanism of lncRNA CERS6-AS1 on the Biological Behavior of Prostate Cancer Cell.

Authors:  Fu Huang; Li Quan Zhou
Journal:  Appl Bionics Biomech       Date:  2022-06-06       Impact factor: 1.664

3.  microRNA-16-5p suppresses cell proliferation and angiogenesis in colorectal cancer by negatively regulating forkhead box K1 to block the PI3K/Akt/mTOR pathway.

Authors:  Xin Huang; Xuan Xu; Huajing Ke; Xiaolin Pan; Jiaoyu Ai; Ruyi Xie; Guilian Lan; Yang Hu; Yao Wu
Journal:  Eur J Histochem       Date:  2022-05-10       Impact factor: 1.966

Review 4.  Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.

Authors:  Seung Wan Son; Han Yeoung Lee; Sokviseth Moeng; Hyo Jeong Kuh; Soo Young Choi; Jong Kook Park
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

Review 5.  microRNAs Mediated Regulation of the Ribosomal Proteins and its Consequences on the Global Translation of Proteins.

Authors:  Abu Musa Md Talimur Reza; Yu-Guo Yuan
Journal:  Cells       Date:  2021-01-08       Impact factor: 6.600

6.  Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients.

Authors:  Roberta Resaz; Davide Cangelosi; Daniela Segalerba; Martina Morini; Paolo Uva; Maria Carla Bosco; Giuseppe Banderali; Ana Estrella; Corbinian Wanner; David A Weinstein; Annalisa Sechi; Sabrina Paci; Daniela Melis; Maja Di Rocco; Young Mok Lee; Alessandra Eva
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

7.  LncRNA LINC00662 Exerts an Oncogenic Effect on Osteosarcoma by the miR-16-5p/ITPR1 Axis.

Authors:  Miao Yu; Weihao Lu; Zhenglin Cao; Tianhang Xuan
Journal:  J Oncol       Date:  2021-09-28       Impact factor: 4.375

8.  TNF-α-stimulated nucleus pulposus cells induce cell apoptosis through the release of exosomal miR-16 targeting IGF-1 and IGF-1R in rats.

Authors:  Qi-Chen Zhang; Yan-Pei Zou; Shun-Qi Hu; Tai-Wei Zhang; Hao Zhou; Bing Liang; Chen-Yang Zhuang; Hui-Ren Wang; Li-Bo Jiang; Xi-Lei Li
Journal:  Ann Transl Med       Date:  2021-09

9.  Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.

Authors:  Hua-Lin Chen; Yi-Ping Luo; Mu-Wen Lin; Xiao-Xia Peng; Mei-Liang Liu; Yong-Cun Wang; Shu-Jun Li; Dong-Hong Yang; Zhi-Xiong Yang
Journal:  Cancer Med       Date:  2022-03-28       Impact factor: 4.711

10.  Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma.

Authors:  Neeti Nadda; Shashi Bala Paul; Dawesh P Yadav; Sonu Kumar; Vishnubhatla Sreenivas; Anoop Saraya; Shivanand Gamanagatti; Subrat Kumar Acharya; Baibaswata Nayak
Journal:  Front Oncol       Date:  2021-02-04       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.